Financial Engines Advisors L.L.C. Abb Vie Inc. Transaction History

Financial Engines Advisors L.L.C.

$44.9 Billion
Q2 2024

A detailed history of Financial Engines Advisors L.L.C. transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Engines Advisors L.L.C. holds 80,610 shares of ABBV stock, worth $15.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

80,610

Previous 76,265 5.7%

Holding current value

$15.6 Million

Previous $13.9 Million 0.44%

% of portfolio

0.03%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $672,562 - $785,402	4,345 Added 5.7%	80,610 $13.8 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $1.4 Million - $1.59 Million	-8,729 Reduced 10.27%	76,265 $13.9 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $77,468 - $87,248	563 Added 0.67%	84,994 $13.2 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $894,518 - $1.04 Million	-6,696 Reduced 7.35%	84,431 $12.6 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $631,675 - $786,078	-4,767 Reduced 4.97%	91,127 $12.3 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $367,598 - $423,344	-2,542 Reduced 2.58%	95,894 $15.3 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.69 Million - $2.02 Million	12,184 Added 14.13%	98,436 $15.9 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $1.84 Million - $2.11 Million	-13,687 Reduced 13.7%	86,252 $11.6 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $768,882 - $977,501	-5,587 Reduced 5.29%	99,939 $15.3 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $633,899 - $786,491	-4,803 Reduced 4.35%	105,526 $17.1 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $671,544 - $849,698	6,251 Added 6.01%	110,329 $14.9 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $727,031 - $825,289	-6,833 Reduced 6.16%	104,078 $11.2 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $1.73 Million - $1.92 Million	-16,404 Reduced 12.88%	110,911 $12.5 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $354,060 - $389,777	-3,461 Reduced 2.65%	127,315 $13.8 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $1.53 Million - $2.07 Million	19,057 Added 17.06%	130,776 $14 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $765,028 - $897,891	-8,905 Reduced 7.38%	111,719 $9.79 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $1.01 Million - $1.34 Million	-13,699 Reduced 10.2%	120,624 $11.8 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $899,065 - $1.36 Million	-13,939 Reduced 9.4%	134,323 $10.2 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $611,734 - $765,410	8,481 Added 6.07%	148,262 $13.1 Million
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $1.62 Million - $1.95 Million	25,741 Added 22.57%	139,781 $10.6 Million
Q2 2019 Aug 09, 2019	SELL	$65.7 - $83.98 $990,164 - $1.27 Million	-15,071 Reduced 11.67%	114,040 $8.29 Million
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $1.09 Million - $1.28 Million	14,143 Added 12.3%	129,111 $10.4 Million
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $963,004 - $1.19 Million	-12,370 Reduced 9.71%	114,968 $10.6 Million
Q3 2018 Nov 02, 2018	SELL	$88.91 - $98.84 $1.13 Million - $1.26 Million	-12,748 Reduced 9.1%	127,338 $11.9 Million
Q2 2018 Jul 27, 2018	SELL	$89.78 - $106.23 $1.33 Million - $1.58 Million	-14,850 Reduced 9.58%	140,086 $13 Million
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $1.85 Million - $2.48 Million	-20,101 Reduced 11.48%	154,936 $14.7 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $4.46 Million - $4.89 Million	-49,775 Reduced 22.14%	175,037 $16.9 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $15.7 Million - $20.1 Million	224,812	224,812 $20 Million

Others Institutions Holding ABBV

# of Institutions

3,693

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Engines Advisors L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Financial Engines Advisors L.L.C. with notifications on news.

Account

Financial Engines Advisors L.L.C. Abb Vie Inc. Transaction History